| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0213-005X(03)72907-3 |
| P698 | PubMed publication ID | 12586023 |
| P2093 | author name string | Carlos Pigrau | |
| P2860 | cites work | Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy | Q40391918 |
| Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. | Q42878542 | ||
| Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial | Q43546278 | ||
| Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid | Q43588787 | ||
| Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison | Q43688970 | ||
| Successful treatment of disseminated Mycobacterium chelonae infection with linezolid | Q43732842 | ||
| Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium | Q43974793 | ||
| Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement | Q44049240 | ||
| Interpretative reading of the antibiogram in gram-positive cocci | Q44140703 | ||
| Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin | Q45199316 | ||
| Oxazolidinones: new players in the battle against multi-resistant Gram-positive bacteria | Q46576587 | ||
| Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group. | Q54027855 | ||
| Linezolid | Q73770356 | ||
| In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates. | Q31815958 | ||
| Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study | Q31918107 | ||
| Oxazolidinone antibiotics. | Q33183184 | ||
| Linezolid: an oxazolidinone antimicrobial agent | Q33336987 | ||
| Linezolid: a review of its use in the management of serious gram-positive infections | Q33337060 | ||
| Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid | Q33942509 | ||
| In vitro activities of LY333328 and comparative agents against nosocomial gram-positive pathogens collected in a 1997 global surveillance study | Q33979559 | ||
| Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections | Q33981016 | ||
| Linezolid therapy of Staphylococcus aureus experimental osteomyelitis | Q33981041 | ||
| Activities of linezolid against rapidly growing mycobacteria | Q33981613 | ||
| Linezolid--a review of the first oxazolidinone | Q34240845 | ||
| Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature | Q34312876 | ||
| Pharmacokinetics and tissue penetration of linezolid following multiple oral doses | Q39477515 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | Spanish | Q1321 |
| P304 | page(s) | 157-64; quiz 165, 169 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Infectious Diseases and Clinical Microbiology | Q15766978 |
| P1476 | title | Oxazolidinones and glycopeptides | |
| P478 | volume | 21 |
| Q39355277 | Antibacterial activity of new oxazolidin-2-one analogues in methicillin-resistant Staphylococcus aureus strains. |
| Q36492157 | In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. |
| Q46501753 | Use of antibiotics for the treatment of multiresistant gram positive cocci infections in critical patients |
Search more.